APA (7th ed.) Citation

Hsieh, P., Chu, P., Cheng, H., Huang, Y., Chou, W., Tsai, K., & Chan, S. (2022). Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation. International Journal of Molecular Sciences, 23(17), 10146. https://doi.org/10.3390/ijms231710146

Chicago Style (17th ed.) Citation

Hsieh, Pei-Ling, Pei-Ming Chu, Hui-Ching Cheng, Yu-Ting Huang, Wan-Ching Chou, Kun-Ling Tsai, and Shih-Hung Chan. "Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation." International Journal of Molecular Sciences 23, no. 17 (2022): 10146. https://doi.org/10.3390/ijms231710146.

MLA (9th ed.) Citation

Hsieh, Pei-Ling, et al. "Dapagliflozin Mitigates Doxorubicin-Caused Myocardium Damage by Regulating AKT-Mediated Oxidative Stress, Cardiac Remodeling, and Inflammation." International Journal of Molecular Sciences, vol. 23, no. 17, 2022, p. 10146, https://doi.org/10.3390/ijms231710146.